Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ARKG | +90.23% | +15.12% | +11.92% | +2.15% | +46.96% | +93.17% | +83.88% | +147.80% | −26.15% | −30.44% |
| TGENOME | +72.30% | +11.84% | +9.48% | +1.95% | +39.16% | +74.32% | +69.70% | +108.70% | −39.44% | −43.31% |
| SCBGENOME(SSF) | +83.97% | +12.68% | +9.83% | +1.58% | +41.61% | +81.31% | +79.08% | +125.21% | −38.08% | −42.06% |
| ASP-IHEALTH | +17.45% | +4.71% | +6.30% | −0.02% | +1.62% | +20.75% | +26.47% | +67.76% | −0.47% | +3.48% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes ARKG: money market or bond funds, or no holdings data yet
| TGENOME | SCBGENOME(SSF) | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 8.90% | 10.03% |
 10x Genomics | 7.84% | 8.02% |
 Tempus AI | 6.99% | 7.15% |
 CRISPR Therapeutics | 4.10% | 4.20% |
 Absci | 3.96% | 4.05% |
| Personalis | 3.82% | 3.91% |
 Natera | 3.92% | 3.63% |
 Guardant Health | 3.61% | 3.69% |
 Illumina | 3.80% | 3.60% |
 CareDx | 3.40% | 3.48% |
30 Dec 2025 → 29 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(SSF) | +83.97% | 41.93% | 2.00 |
| ARKG | +90.23% | 46.37% | 1.95 |
| TGENOME | +72.30% | 39.67% | 1.82 |
| ASP-IHEALTH | +17.45% | 24.99% | 0.70 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | ARKG | TGENOME | SCBGENOME(SSF) | ASP-IHEALTH |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 1,343 million | 43.72 million | 138 million |
| Inception date | N/A | 13 Jan 2021 | 20 Aug 2021 | 29 Mar 2019 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) | กองทุน ARK Genomic Revolution ETF | กองทุนที่ลงทุนหลายกอง (JHHBIU2 LX, ARKG US) |
| Dividend policy | N/A | Does not pay | Pays | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Almost fully hedged |
| Share hedged | N/A | 84.93% | 57.68% | 100.14% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1,000 THB | 1,000 THB | 1,000 THB |
| Subsequent purchase | N/A | 1,000 THB | 1,000 THB | 1,000 THB |
| Redemption (amount) | N/A | No minimum | No minimum | No minimum |
| Redemption (units) | N/A | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+3 | T+4 | T+5 |
